MTOR and cancer: mTOR inhibitor treatment in non-cancer cell lines increases polyomavirus LT-antigen expression and directly activates polyomavirus replication by inhibiting S-phase kinase-associated protein 2 (Skp2) E3 ligase at non-cytotoxic concentrations (7, 8).